A popular diabetes drug just got a major new approval — and it could be a game-changer for millions of Americans at risk for kidney failure.

The FDA’s recent approval of OZEMPIC highlights the expanding use of GLP-1 drugs beyond diabetes and weight management. Novo Nordisk’s blockbuster medication has gained another label expansion, now ...

Sotagliflozin significantly reduces heart attacks and strokes in high-risk patients with diabetes and kidney disease, ...

Lupin has received tentative approval from the Food and Drug Administration for darunavir, cobicistat, emtricitabine, and ...

An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...

Travere Therapeutics shares rose sharply in early trading Tuesday after the biopharmaceutical company said it plans to seek expanded Food and Drug Administration approval of its kidney-disease drug ...

Over 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study. By creating the most complete and detailed genetic 'map' of kidney function to ...

Millions of Americans take proton pump inhibitors (PPIs) like Prilosec, Nexium, and Prevacid to manage acid reflux, heartburn, and gastroesophageal reflux disease (GERD).

Study led by Mount Sinai researcher shows sotagliflozin is the only drug in its class to demonstrate these results ...

Type C Meeting Requested to Accelerate XRx-026 for Gout to NDA ● CALGARY, Alberta, (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) ( ...

Researchers estimate that as many as 840 million people globally live with chronic kidney disease — a disease ... Endocrinology has found that a U.S. FDA-approved medication already used to ...